FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/08/2022
Voltar para busca
Dado oficial do USPTO
ODI PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ODI PHARMA
ST13
US500000079279092Classe
31, 34, 41, 42
Pedido
79279092
Registro
6634942
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
09/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
31, 34, 41, 42
Data de depósito
22/11/2019
Data de registro
08/02/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/02/2022
Última transação
08/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SE
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ODI Pharma AB
Representantes
Andrea Anderson Holland & Hart LLP
Classificação técnica
Classes Nice
Classe 31Classe 34Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 31
Malt for brewing and distilling with none of the foregoing containing any hemp or CBD; Malt for brewing and distilling and not for the production of consumable goods; cannabisunprocessedloose hemp to be used for producing hemp-based skincare products; all of the foregoing goods that contain hemp with no CBD and all of the foregoing goods that contain hemp and CBD are derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Classe 34
Cigarette tobaccoraw tobaccocigarscigarettessnuffchewing tobacco with all of the foregoing containing CBD that is solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; cigarette tobaccoraw tobaccocigarscigarettessnuffchewing tobacco with none of the foregoing containing any hemp or CBD; articles for use with tobaccoashtraystobacco pipespipe racks for tobacco pipespipe cleaners for tobacco pipespocket machines for rolling cigarettestobacco filters
Classe 41
Educational and training servicesclasses in the field of healthcare and pharmaceuticals; arranging and conducting of educational conferences; arrangingconducting and organisation of educational symposiums; arranging and conducting educational conferences and seminars
Classe 42
industrial research in the field of pharmaceuticals; analytical laboratory services in the fields of medicine and pharmaceuticals; research laboratories in the fields of medicine and pharmaceuticals; providing information about industrial analysis and research services in the fields of medicine and pharmaceuticals; all the aforementioned excluding hemp analytical and research testing services
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/07/2022
FIMP
FINAL DISPOSITION PROCESSED
14/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
28/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/11/2021
PUBO
PUBLISHED FOR OPPOSITION
23/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/10/2021
ALIE
ASSIGNED TO LIE
14/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/10/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
14/10/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/10/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
14/10/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/10/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/10/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
20/09/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/09/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
20/09/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/08/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/08/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/07/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/07/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/04/2021
GNFR
FINAL REFUSAL E-MAILED
05/04/2021
CNFR
FINAL REFUSAL WRITTEN
05/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2021
RFNT
REFUSAL PROCESSED BY IB
18/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2020
RFRR
REFUSAL PROCESSED BY MPU
27/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
08/09/2020
DOCK
ASSIGNED TO EXAMINER
01/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/05/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/02/2020
DOCK
ASSIGNED TO EXAMINER
27/02/2020
DOCK
ASSIGNED TO EXAMINER
26/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ODI PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.